» Articles » PMID: 27076895

The Effect of Diabetes Mellitus on Apoptosis in Hippocampus: Cellular and Molecular Aspects

Overview
Journal Int J Prev Med
Date 2016 Apr 15
PMID 27076895
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Diabetes mellitus is associated with cognitive deficits in humans and animals. These deficits are paralleled by neurophysiological and structural changes in brain. In diabetic animals, impairments of spatial learning, memory, and cognition occur in association with distinct changes in hippocampus, a key brain area for many forms of learning and memory and are particularly sensitive to changes in glucose homeostasis. However, the multifactorial pathogenesis of diabetic encephalopathy is not yet completely understood. Apoptosis plays a crucial role in diabetes-induce neuronal loss in hippocampus.

Methods: The effects of diabetes on hippocampus and cognitive/behavioral dysfunctions in experimental models of diabetes are reviewed, with a focus on the negative impact on increased neuronal apoptosis and related cellular and molecular mechanisms.

Results: Of all articles that were assessed, most of the experimental studies clearly showed that diabetes causes neuronal apoptosis in hippocampus through multiple mechanisms, including oxidative stress, inhibition of caspases, disturbance in expression of apoptosis regulator genes, as well as deficits in mitochondrial function. The balance between pro-apoptotic and anti-apoptotic signaling may determine the neuronal apoptotic outcome in vitro and in vivo models of experimental diabetes.

Conclusions: Dissecting out the mechanisms responsible for diabetes-related changes in the hippocampal cell apoptosis helps improve treatment of impaired cognitive and memory functions in diabetic individuals.

Citing Articles

Alpha-Lipoic Acid Reduces Neuroinflammation and Oxidative Stress Induced by Dapsone in an Animal Model.

Gomes B, Santos S, Gato L, Espindola K, Silva R, Davis K Nutrients. 2025; 17(5).

PMID: 40077661 PMC: 11901491. DOI: 10.3390/nu17050791.


In Vivo and Computational Studies on Sitagliptin's Neuroprotective Role in Type 2 Diabetes Mellitus: Implications for Alzheimer's Disease.

Mani V, Arfeen M Brain Sci. 2025; 14(12.

PMID: 39766390 PMC: 11674309. DOI: 10.3390/brainsci14121191.


Electroacupuncture improves diabetic cognitive impairment rats by suppressing NLRP3 inflammasome activation via induction of mitophagy.

Ge X, Zhang L, Ye M, Fei A, Wang L, Yuan A Metab Brain Dis. 2024; 40(1):14.

PMID: 39560708 PMC: 11576777. DOI: 10.1007/s11011-024-01464-y.


Neuroprotective Effects of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors (Gliflozins) on Diabetes-Induced Neurodegeneration and Neurotoxicity: A Graphical Review.

Gholami M, Coleman-Fuller N, Salehirad M, Darbeheshti S, Motaghinejad M Int J Prev Med. 2024; 15:28.

PMID: 39239308 PMC: 11376549. DOI: 10.4103/ijpvm.ijpvm_5_23.


SGLT2 inhibitors: a novel therapy for cognitive impairment via multifaceted effects on the nervous system.

Mei J, Li Y, Niu L, Liang R, Tang M, Cai Q Transl Neurodegener. 2024; 13(1):41.

PMID: 39123214 PMC: 11312905. DOI: 10.1186/s40035-024-00431-y.


References
1.
Hung R, Chow A . Apoptosis: Molecular mechanisms, regulation and role in pathogenesis. Can J Infect Dis. 2012; 8(2):103-9. PMC: 3327349. DOI: 10.1155/1997/131305. View

2.
Biessels G, Kamal A, Urban I, Spruijt B, Erkelens D, Gispen W . Water maze learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: effects of insulin treatment. Brain Res. 1998; 800(1):125-35. DOI: 10.1016/s0006-8993(98)00510-1. View

3.
Huber C, Schwenkglenks M, Rapold R, Reich O . Epidemiology and costs of diabetes mellitus in Switzerland: an analysis of health care claims data, 2006 and 2011. BMC Endocr Disord. 2014; 14:44. PMC: 4048540. DOI: 10.1186/1472-6823-14-44. View

4.
Kukhta V, Marozkina N, Sokolchik I, Bogaturova E . Molecular mechanisms of apoptosis. Ukr Biokhim Zh (1999). 2004; 75(6):5-9. View

5.
Chuiko M, Bodykhov M, Skvortsova V . [Characteristics and peculiarities of the course of encephalopathy in diabetes mellitus]. Zh Nevrol Psikhiatr Im S S Korsakova. 2011; 110(5 Pt 1):4-8. View